Vimarsana
Biggest News Aggregation in the World

Page 2 - Hemostasis Network News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hemostasis Network. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hemostasis Network Today - Breaking & Trending Today

Pendo Exceeds Goals for New Adopt Solution in Latest Quarter of Rapid Growth - Vimarsana News

Pendo Exceeds Goals for New Adopt Solution in Latest Quarter of Rapid Growth

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Pendo Exceeds Goals for New Adopt Solution in Latest Quarter of Rapid Growth - Vimarsana News

Pendo Exceeds Goals for New Adopt Solution in Latest Quarter of Rapid Growth

/PRNewswire/ -- Pendo, the most comprehensive product-led platform, today announced highlights from its first quarter, which ended April 30, 2022. Notable...

Increasing Access to Care for Hemophilia - Vimarsana News

Increasing Access to Care for Hemophilia

Hemophilia is a rare genetic disorder that prevails across many countries worldwide. This article looks at increasing access to hemophilia care.

LFB Announces that the European Medicines Agency (EMA) Has Accepted for Filing the Marketing Authorization Application for eptacog beta (activated), a Recombinant Coagulation Factor VIIa - Vimarsana News

LFB Announces that the European Medicines Agency (EMA) Has Accepted for Filing the Marketing Authorization Application for eptacog beta (activated), a Recombinant Coagulation Factor VIIa

Published: Mar 01, 2021 LES ULIS, France--(BUSINESS WIRE)-- Regulatory News: LFB today announced that the European Medicines Agency (EMA), the European regulatory authority, has accepted for filing the Marketing Authorization Application for eptacog beta, a recombinant coagulation Factor VIIa (rFVIIa). The application includes data from three prospective phase 3 clinical trials (PERSEPT 1, PERSEPT 2, and PERSEPT 3) assessing the efficacy and safety of eptacog beta in the treatment of bleeding episodes in children and adults with congenital haemophilia A or B with inhibitors and for the pr...